LSB
Price
$1.00
Change
-$0.00 (-0.00%)
Updated
Jun 6 closing price
Capitalization
19.06M
VIVS
Price
$1.84
Change
-$0.00 (-0.00%)
Updated
Jun 6 closing price
Capitalization
3.3M
Interact to see
Advertisement

LSB vs VIVS

Header iconLSB vs VIVS Comparison
Open Charts LSB vs VIVSBanner chart's image
LakeShore Biopharma
Price$1.00
Change-$0.00 (-0.00%)
Volume$89.08K
Capitalization19.06M
VivoSim Lab
Price$1.84
Change-$0.00 (-0.00%)
Volume$38.99K
Capitalization3.3M
LSB vs VIVS Comparison Chart
Loading...
LSB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LSB vs. VIVS commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LSB is a Hold and VIVS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (LSB: $1.07 vs. VIVS: $1.92)
Brand notoriety: LSB and VIVS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LSB: 17% vs. VIVS: 6%
Market capitalization -- LSB: $19.06M vs. VIVS: $3.3M
LSB [@Biotechnology] is valued at $19.06M. VIVS’s [@Biotechnology] market capitalization is $3.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LSB’s FA Score shows that 1 FA rating(s) are green whileVIVS’s FA Score has 0 green FA rating(s).

  • LSB’s FA Score: 1 green, 4 red.
  • VIVS’s FA Score: 0 green, 5 red.
According to our system of comparison, VIVS is a better buy in the long-term than LSB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LSB’s TA Score shows that 5 TA indicator(s) are bullish while VIVS’s TA Score has 3 bullish TA indicator(s).

  • LSB’s TA Score: 5 bullish, 2 bearish.
  • VIVS’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, LSB is a better buy in the short-term than VIVS.

Price Growth

LSB (@Biotechnology) experienced а -2.73% price change this week, while VIVS (@Biotechnology) price change was -1.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LSB($19.1M) has a higher market cap than VIVS($3.3M). VIVS YTD gains are higher at: 317.482 vs. LSB (-69.075).
LSBVIVSLSB / VIVS
Capitalization19.1M3.3M578%
EBITDA-220.1MN/A-
Gain YTD-69.075317.482-22%
P/E RatioN/AN/A-
Revenue672MN/A-
Total Cash49.5MN/A-
Total Debt369MN/A-
FUNDAMENTALS RATINGS
VIVS: Fundamental Ratings
VIVS
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
PROFIT vs RISK RATING
1..100
90
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LSBVIVS
RSI
ODDS (%)
Bullish Trend 12 days ago
86%
N/A
Stochastic
ODDS (%)
Bullish Trend 12 days ago
80%
Bullish Trend 12 days ago
85%
Momentum
ODDS (%)
N/A
Bullish Trend 12 days ago
83%
MACD
ODDS (%)
Bullish Trend 12 days ago
54%
N/A
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
71%
Bearish Trend 12 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
77%
Bullish Trend 12 days ago
81%
Advances
ODDS (%)
Bullish Trend 20 days ago
72%
Bullish Trend about 1 month ago
81%
Declines
ODDS (%)
Bearish Trend 13 days ago
88%
Bearish Trend about 1 month ago
88%
BollingerBands
ODDS (%)
Bullish Trend 12 days ago
68%
N/A
Aroon
ODDS (%)
Bearish Trend 12 days ago
87%
Bearish Trend 12 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
LSB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

LSB and

Correlation & Price change

A.I.dvisor indicates that over the last year, LSB has been loosely correlated with GLTO. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if LSB jumps, then GLTO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LSB
1D Price
Change %
LSB100%
+1.91%
GLTO - LSB
33%
Loosely correlated
+0.67%
APM - LSB
26%
Poorly correlated
-2.49%
VIVS - LSB
24%
Poorly correlated
+0.52%
IMRX - LSB
22%
Poorly correlated
+9.76%
SKYE - LSB
20%
Poorly correlated
-9.55%
More

VIVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIVS has been loosely correlated with GLTO. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if VIVS jumps, then GLTO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIVS
1D Price
Change %
VIVS100%
+0.52%
GLTO - VIVS
38%
Loosely correlated
+0.67%
KRRO - VIVS
26%
Poorly correlated
-3.12%
ADIL - VIVS
25%
Poorly correlated
+1.49%
BEAM - VIVS
25%
Poorly correlated
-0.88%
HLVX - VIVS
24%
Poorly correlated
-1.61%
More